The last day of February each year is Rare Disease Day!

Begun in Sweden in 2008, Rare Disease*1 Day (RDD) is observed on the final day of February every year—on the 28th, or 29th in leap years—to coincide with the “rarest day” of the year. The goal of this day is to work towards improving the quality of life of patients suffering from rare diseases through better diagnosis and therapy, and there are many different initiatives run in tandem with it each year.

In recent years RDD events have been held in 100 countries, making it the world’s largest public awareness activity for rare diseases.

Kyowa Kirin’s philosophy is to “contribute to the health and well-being of people around the world, and they put focus on patient advocacy (PA)*2 that aims to value patients’ own experiences when creating better healthcare and living conditions.

RDD calls for greater support from the patient’s perspective so that no one with a rare disease is left behind, and can be seen as a day that embodies PA and Kyowa Kirin’s philosophy. This is why each year in the period surrounding RDD, Kyowa Kirin works to raise awareness in each global region and calls for understanding and support, both within the company and amongst the general public. So what kind of activities were held in Asia Pacific?

  • *1:
    Diseases for which there is little research into therapies and drug development due to the small number of patients and complexity of the disease mechanisms.
  • *2:
    The concept of promoting correct understanding of a disease and creating better therapies and living conditions through active dialogue and cooperation between patients, doctors and pharmaceutical companies.
Image:300 million people worldwide living with a rare diseaseOpen in new window
This link is to the latest information, RDD 2023.

Increasing understanding of patients and caregivers’ experiences with XLH in Australia

Kyowa Kirin AustraliaOpen in new window teamed up with X-linked hypophosphatemia (XLH) patient support group XLH Australia (XLHA)Open in new window to conduct the first-ever local survey of patients and their families about the physical, mental, social and economic impacts of living with the disease. The survey revealed that 51% of patients feel that their mental health has been affected, while 83% struggle with low self-esteem. The resultsOpen in new window are providing more people with the opportunity to better understand what it’s like to live with XLH.

Joining a movement to support local rare disease communities

In February of this year, Kyowa Kirin Asia Pacific Pte.Ltd. took part in the Carry Hope Challenge 2022Open in new window organized by the Rare Disorders Society (Singapore), or RDSS. The challenge aims to spread awareness about rare diseases and raise funds to support patients’ home-based learning and therapy. Participants carry a plush toy of RDSS’s sloth mascot “Hope” on a 7.7km walk, run or cycle, then share their adventure with others through social media. According to the RDSS website, physically carrying the stuffed sloths to different locations is akin to carrying the beneficiaries’ hopes on their behalf and spreading their hopes to as many places as possible.

More than 20 Kyowa Kirin employees from Singapore, Japan, Malaysia and Australia joined the challenge, with the company supporting their participation with a matching donation. Afterwards, photos and videos of the event were shared on the company social intranet, LinkedIn and other social media. Participants were motivated by the opportunity to not only raise awareness but also support patients themselves.

Image: In front of Singapore’s iconic Marina Bay Sands hotel.
Image: On the Story Bridge in Brisbane, Australia
Image: One colleague even made a photo diary of their trip around Singapore.
Our LinkedIn postOpen in new window about the challenge has received more than 1,200 unique impressions.

Ensuring the focus remains on patients

Kyowa Kirin Asia Pacific Pte.Ltd. listened to the voices of patients and sought to participate in initiatives that provide them with direct support. They’ll now take the lessons they’ve learned and apply them to help better address patient-centric healthcare needs in the future.

The activities mentioned in the article were conducted in the Asia Pacific Region under the relevant laws and regulations of each country.

More Kyowa Kirin "Patients" Stories

Strengthening our training framework to tackle the biopharmaceutical engineer shortage

People & Culture | September 20, 2024

Highlighting Kyowa Kirin's initiatives across regions for PRIDE MONTH 2024

People & Culture | September 13, 2024

Bio Adventure: Kyowa Kirin’s works with local communities on project to foster future scientists

People & Culture | August 9, 2024

PRIDE MONTH Message from Jeremy Morgan, President, Kyowa Kirin International plc (EMEA region)

People & Culture | July 5, 2024

Kyowa Kirin launches the CTCL Global Care Collaborative’s Time to Act global consensus statement

Patients | May 13, 2024

Kyowa Kirin Global Corporate Planning Head Shoko Itagaki’s Message for International Women's Day

People & Culture | March 8, 2024

Kyowa Kirin celebrates Rare Disease Day 2024 across the world

Patients | February 9, 2024

Kyowa Kirin CEO Miyamoto’s New Year Message

Growth | January 9, 2024

Kyowa Kirin Chief International Business Officer Abdul Mullick’s Message on UN’s International Day of Persons with Disabilities

Sustainability | December 1, 2023

Kyowa Kirin hosted a booth for the first time at the Tokyo Rainbow Pride 2023 [Our Diversity, Equity & Inclusion]

People & Culture | November 9, 2023

Our Stable Supply of High-quality Pharmaceuticals

Sustainability | September 20, 2023

Provide pharmaceuticals for unmet medical needs - A Conversation with Kyowa Kirin’s R&D Executives

Innovation | August 22, 2023PDF file

Ensure a Thriving Global Environment for Future Generations

Sustainability | July 28, 2023

“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅡ

People & Culture | June 9, 2023

How Kyowa Kirin Celebrated Rare Disease Day 2023 around The World

Patients | May 18, 2023

“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅠ

People & Culture | April 25, 2023

Kyowa Kirin CEO Miyamoto’s Message on Rare Disease Day

Patients | February 28, 2023

Promoting patient advocacy and nurturing patient-centric care: Interview with Kyowa Kirin North America

Patients | February 14, 2023

Celebrating another year of diverse initiatives around the world: RDD 2022 in EMEA

Patients | January 24, 2023

Celebrating another year of diverse initiatives around the world: RDD 2022 in North America

Patients | December 15, 2022

Celebrating another year of diverse initiatives around the world: RDD 2022 in Asia Pacific

Patients | November 21, 2022

Celebrating another year of diverse initiatives around the world: RDD 2022 in Japan

Patients | October 20, 2022

Providing high-quality pharmaceuticals to patients around the world

Sustainability | September 22, 2022

Striving to create life-changing “Only-one value” that brings smiles to patients

Innovation | July 25, 2022

Kyowa Kirin International: It's Time to Shine A Light on XLH

Patients | June 27, 2022

Kyowa Kirin CEO Miyamoto’s Message on Pride Month

People & Culture | June 9, 2022

Kyowa Kirin International Celebrates the UN’s International Day of Persons with Disabilities in EMEA

People & Culture | January 20, 2022

Kyowa Kirin International: Around the world challenge

People & Culture | December 17, 2021Open in new window

Kyowa Kirin North America: Honoring The Caregiver, Everyday Heroes, During National Family Caregivers Month

Patients | November 19, 2021

Kyowa Kirin's Effort to Realize a Sustainable Society

Sustainability | October 11, 2021

Our Financial Strategy for Creating Life-changing Value

Growth | September 9, 2021

Changes in society caused by COVID-19 and the impact on Kyowa Kirin

Growth | August 19, 2021

Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break

Sustainability | July 27, 2021

AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS

News Release | June 1, 2021

MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting

News Release | May 20, 2021

White Paper on the unrecognized burden of XLH in adults in Europe

Patients | July 13, 2020

Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (First Half)

People & Culture | March 5, 2020

Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (Second Half)

People & Culture | March 5, 2020

“Delivering smiles with sports” Creating an inclusive society through table tennis

Sustainability | January 14, 2020

Bio Adventure*: Kyowa Kirin Invites Children to a Science Adventure

People & Culture | July 3, 2019

Return to Stories